ERBB2 and breast cancer: Preclinical studies for the development of DC vaccines for BC have also shown promising results: Sakai et al. modified DCs by transducing them with a non-signaling neu oncogene which resulted in no mammary tumor development in BALB-neu transgenic mice [82].